Found 2 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Leukotriene A-4 hydrolase
(Homo sapiens (Human)) | BDBM327136
(1-(1-{4-[(2S)-2,3-dihydro-1,4- benzodioxin-2- yl...)Show SMILES NC(=O)NC1CCN(Cc2ccc(cc2)[C@H]2COc3ccccc3O2)CC1 |r| Show InChI InChI=1S/C21H25N3O3/c22-21(25)23-17-9-11-24(12-10-17)13-15-5-7-16(8-6-15)20-14-26-18-3-1-2-4-19(18)27-20/h1-8,17,20H,9-14H2,(H3,22,23,25)/t20-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 0.220 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH
US Patent
| Assay Description The compounds of the invention are assessed for the ability to interact with human LTA4 hydrolase in an enzymatic assay that measures the ability of ... |
US Patent US9662339 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q8D |
More data for this Ligand-Target Pair | |
Leukotriene A-4 hydrolase
(Homo sapiens (Human)) | BDBM327126
(1-{1-[4-(2,3-dihydro-1,4- benzodioxin-2- yl)benz...)Show InChI InChI=1S/C21H25N3O3/c22-21(25)23-17-9-11-24(12-10-17)13-15-5-7-16(8-6-15)20-14-26-18-3-1-2-4-19(18)27-20/h1-8,17,20H,9-14H2,(H3,22,23,25) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 0.420 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH
US Patent
| Assay Description The compounds of the invention are assessed for the ability to interact with human LTA4 hydrolase in an enzymatic assay that measures the ability of ... |
US Patent US9662339 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q8D |
More data for this Ligand-Target Pair | |